FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. (Q53080836)

11 May 2018

title

FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. (English)

1 reference

11 May 2018

Fluorodeoxyglucose Positron Emission Tomography

main subject

1 reference

5

1 reference

11 May 2018

Val J. Lowe

4

object named as

Val Lowe

1 reference

11 May 2018

Jennifer L Whitwell

3

object named as

Jennifer L Whitwell

1 reference

11 May 2018

author name string

Nicholas Zalewski

1

1 reference

11 May 2018

Hugo Botha

2

1 reference

11 May 2018

Keith A Josephs

6

1 reference

11 May 2018

publication date

4 February 2014

1 reference

11 May 2018

published in

Journal of Neurology

1 reference

11 May 2018

volume

261

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

710-716

1 reference

11 May 2018

Corticobasal degeneration: neuropathologic and clinical heterogeneity

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Is FDG‐PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

FDG PET in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Typical cerebral metabolic patterns in neurodegenerative brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Cerebral glucose metabolism, clinical, neuropsychological, and radiological profile in patients with corticobasal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Neuropathology of variants of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

Atypical progressive supranuclear palsy with corticospinal tract degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

The pimple sign of progressive supranuclear palsy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7256-4

18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes

21 January 2018

1 reference

12 December 2020

Globular glial tauopathies (GGT): consensus recommendations

1 reference

12 December 2020

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

12 December 2020

Voxel-based distribution of metabolic impairment in corticobasal degeneration

1 reference

12 December 2020

PET measures of benzodiazepine receptors in progressive supranuclear palsy

1 reference

12 December 2020

10.1007/S00415-014-7256-4

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018